, Agreement on mutual recognition between the European Community and the United States of…

In forcesince 1 Mar 2017

Each Party will apply the following criteria to determine whether to recognize an authority listed in Appendix 2:

(i)

The authority has the legal and regulatory authority to conduct inspections against a standard for GMP (as defined in Article 1).

(ii)

The authority manages conflict of interest in an ethical manner.

(iii)

The authority has the ability to evaluate risks and mitigate them.

(iv)

The authority maintains appropriate oversight of manufacturing facilities within its jurisdiction.

(v)

The authority has and uses sufficient resources.

(vi)

The authority employs trained and qualified inspectors with the skills and knowledge to identify manufacturing practices that may lead to patient harm.

(vii)

The authority has the tools necessary to take action to protect the public from harm due to poor quality drugs or medicinal products.